Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Gautier-Veyret, Elodie
22  Ergebnisse:
Artikel (Online) X
Personensuche X
?
1

Comment on 'Therapeutic drug monitoring-guided treatment ve..:

Gautier-Veyret, Elodie ; Thiebaut-Bertrand, Anne ; Stanke-Labesque, Françoise
International Journal of Antimicrobial Agents.  62 (2023)  2 - p. 106853 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Early Exposure of Kidney Transplant Recipients with Chronic..:

Arrivé, Capucine ; Jacquet, Marvin ; Gautier-Veyret, Elodie...
Journal of Clinical Medicine.  12 (2023)  22 - p. 7141 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Variability of Isavuconazole Trough Concentrations during L..:

Bolcato, Léa ; Thiebaut-Bertrand, Anne ; Stanke-Labesque, Françoise.
Journal of Clinical Medicine.  11 (2022)  19 - p. 5756 , 2022
Link: https://doi.org/10.3390/..
 
?
4

Variability of Tacrolimus Trough Concentration in Liver Tra..:

Chavant, Anaelle ; Fonrose, Xavier ; Gautier-Veyret, Elodie...
Pharmaceutics.  13 (2021)  11 - p. 1960 , 2021
Link: https://doi.org/10.3390/..
 
?
5

Simultaneous quantification of rituximab and eculizumab in ..:

Truffot, Aurélie ; Jourdil, Jean-François ; Seitz-Polski, Barbara...
Clinical Biochemistry.  87 (2021)  - p. 60-66 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Tocilizumab Trough Levels Variability in Kidney-Transplant ..:

Truffot, Aurélie ; Jouve, Thomas ; Noble, Johan...
Journal of Clinical Medicine.  11 (2021)  1 - p. 91 , 2021
Link: https://doi.org/10.3390/..
 
?
7

Modeling Approach to Predict the Impact of Inflammation on ..:

Simon, Florian ; Gautier-Veyret, Elodie ; Truffot, Aurélie...
Pharmaceutical Research.  38 (2021)  3 - p. 415-428 , 2021
Link: https://doi.org/10.1007/..
 
?
8

Combined Impact of Inflammation and Pharmacogenomic Variant..:

Bolcato, Léa ; Khouri, Charles ; Veringa, Anette...
Journal of Clinical Medicine.  10 (2021)  10 - p. 2089 , 2021
Link: https://doi.org/10.3390/..
 
?
9

Inflammation is a major regulator of drug metabolizing enzy..:

Stanke-Labesque, Françoise ; Gautier-Veyret, Elodie ; Chhun, Stephanie.
Pharmacology & Therapeutics.  215 (2020)  - p. 107627 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Using unusual drug-drug interactions to maximize voriconazo..:

Boglione-Kerrien, Christelle ; Verdier, Marie-Clémence ; Gautier-Veyret, Elodie...
Médecine et Maladies Infectieuses.  49 (2019)  7 - p. 555-557 , 2019
Link: https://doi.org/10.1016/..
 
?
11

A multiplex liquid chromatography tandem mass spectrometry ..:

Willeman, Théo ; Jourdil, Jean-François ; Gautier-Veyret, Elodie..
Analytica Chimica Acta.  1067 (2019)  - p. 63-70 , 2019
Link: https://doi.org/10.1016/..
 
?
12

Which place of pharmacological approaches beyond continuous..:

Gautier-Veyret, Elodie ; Pépin, Jean-Louis ; Stanke-Labesque, Françoise
Pharmacology & Therapeutics.  186 (2018)  - p. 45-59 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Inhibition of Voriconazole Metabolism by Meropenem: A Role ..:

Truffot, Aurélie ; Thiebaut-Bertrand, Anne ; Chapuis, Claire..
Clinical Infectious Diseases.  66 (2018)  10 - p. 1643-1644 , 2018
Link: https://doi.org/10.1093/..
 
?
14

Cysteinyl-leukotriene pathway as a new therapeutic target f..:

Gautier-Veyret, Elodie ; Bäck, Magnus ; Arnaud, Claire...
Pharmacological Research.  134 (2018)  - p. 311-319 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Infliximab quantitation in human plasma by liquid chromatog..:

Jourdil, Jean-Francois ; Lebert, Dorothée ; Gautier-Veyret, Elodie...
Analytical and Bioanalytical Chemistry.  409 (2016)  5 - p. 1195-1205 , 2016
Link: https://doi.org/10.1007/..
 
1-15